|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:XPR1-KHDRBS1 (FusionGDB2 ID:99056) |
Fusion Gene Summary for XPR1-KHDRBS1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: XPR1-KHDRBS1 | Fusion gene ID: 99056 | Hgene | Tgene | Gene symbol | XPR1 | KHDRBS1 | Gene ID | 9213 | 10657 |
Gene name | xenotropic and polytropic retrovirus receptor 1 | KH RNA binding domain containing, signal transduction associated 1 | |
Synonyms | IBGC6|SLC53A1|SYG1|X3 | Sam68|p62|p68 | |
Cytomap | 1q25.3 | 1p35.2 | |
Type of gene | protein-coding | protein-coding | |
Description | xenotropic and polytropic retrovirus receptor 1X-receptorprotein SYG1 homologsolute carrier family 53 (phosphate exporter), member 1xenotropic and polytropic murine leukemia virus receptor X3 | KH domain-containing, RNA-binding, signal transduction-associated protein 1GAP-associated tyrosine phosphoprotein p62 (Sam68)KH domain containing, RNA binding, signal transduction associated 1p21 Ras GTPase-activating protein-associated p62src-associa | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | . | Q07666 | |
Ensembl transtripts involved in fusion gene | ENST00000367590, ENST00000367589, ENST00000467345, | ENST00000327300, ENST00000307714, ENST00000492989, | |
Fusion gene scores | * DoF score | 24 X 7 X 12=2016 | 11 X 8 X 6=528 |
# samples | 27 | 12 | |
** MAII score | log2(27/2016*10)=-2.90046432644909 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(12/528*10)=-2.13750352374993 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: XPR1 [Title/Abstract] AND KHDRBS1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | XPR1(180651547)-KHDRBS1(32495899), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | KHDRBS1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 24514149 |
Tgene | KHDRBS1 | GO:0007166 | cell surface receptor signaling pathway | 9045636 |
Tgene | KHDRBS1 | GO:0031647 | regulation of protein stability | 21613532 |
Tgene | KHDRBS1 | GO:0045948 | positive regulation of translational initiation | 21613532 |
Tgene | KHDRBS1 | GO:0046833 | positive regulation of RNA export from nucleus | 21613532 |
Fusion gene breakpoints across XPR1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across KHDRBS1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8060-01A | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
Top |
Fusion Gene ORF analysis for XPR1-KHDRBS1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000367590 | ENST00000327300 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
5CDS-3UTR | ENST00000367590 | ENST00000307714 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
5CDS-3UTR | ENST00000367590 | ENST00000492989 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
In-frame | ENST00000367589 | ENST00000327300 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
5CDS-3UTR | ENST00000367589 | ENST00000307714 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
5CDS-3UTR | ENST00000367589 | ENST00000492989 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
intron-3CDS | ENST00000467345 | ENST00000327300 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
intron-3UTR | ENST00000467345 | ENST00000307714 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
intron-3UTR | ENST00000467345 | ENST00000492989 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000367590 | XPR1 | chr1 | 180651547 | + | ENST00000327300 | KHDRBS1 | chr1 | 32495899 | + | 2527 | 319 | 198 | 1268 | 356 |
ENST00000367589 | XPR1 | chr1 | 180651547 | + | ENST00000327300 | KHDRBS1 | chr1 | 32495899 | + | 2499 | 291 | 170 | 1240 | 356 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000367590 | ENST00000327300 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + | 0.000250027 | 0.99974996 |
ENST00000367589 | ENST00000327300 | XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495899 | + | 0.000235386 | 0.9997646 |
Top |
Fusion Genomic Features for XPR1-KHDRBS1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495898 | + | 3.17E-12 | 1 |
XPR1 | chr1 | 180651547 | + | KHDRBS1 | chr1 | 32495898 | + | 3.17E-12 | 1 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for XPR1-KHDRBS1 |
Go to FGviewer for the breakpoints of chr1:180651547-chr1:32495899 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | KHDRBS1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain-containing proteins. Role in G2-M progression in the cell cycle. Represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. Also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export. Positively regulates the association of constitutive transport element (CTE)-containing mRNA with large polyribosomes and translation initiation. According to some authors, is not involved in the nucleocytoplasmic export of unspliced (CTE)-containing RNA species according to (PubMed:22253824). RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). Can regulate CD44 alternative splicing in a Ras pathway-dependent manner (By similarity). In cooperation with HNRNPA1 modulates alternative splicing of BCL2L1 by promoting splicing toward isoform Bcl-X(S), and of SMN1 (PubMed:17371836, PubMed:20186123). Can regulate alternative splicing of NRXN1 and NRXN3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners. In a neuronal activity-dependent manner cooperates synergistically with KHDRBS2/SLIM-1 in regulation of NRXN1 exon skipping at AS4. The cooperation with KHDRBS2/SLIM-1 is antagonistic for regulation of NXRN3 alternative splicing at AS4 (By similarity). {ECO:0000250|UniProtKB:Q60749, ECO:0000269|PubMed:15021911, ECO:0000269|PubMed:17371836, ECO:0000269|PubMed:20186123, ECO:0000269|PubMed:20610388, ECO:0000269|PubMed:22253824, ECO:0000269|PubMed:26758068}.; FUNCTION: Isoform 3, which is expressed in growth-arrested cells only, inhibits S phase. {ECO:0000269|PubMed:9013542}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 282_292 | 127.33333333333333 | 444.0 | Compositional bias | DMA/Gly-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 295_301 | 127.33333333333333 | 444.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 302_332 | 127.33333333333333 | 444.0 | Compositional bias | Arg/Gly-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 334_363 | 127.33333333333333 | 444.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 282_292 | 127.33333333333333 | 405.0 | Compositional bias | DMA/Gly-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 295_301 | 127.33333333333333 | 405.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 302_332 | 127.33333333333333 | 405.0 | Compositional bias | Arg/Gly-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 334_363 | 127.33333333333333 | 405.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 171_197 | 127.33333333333333 | 444.0 | Domain | KH | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 171_197 | 127.33333333333333 | 405.0 | Domain | KH |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 1_177 | 40.333333333333336 | 632.0 | Domain | SPX |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 439_643 | 40.333333333333336 | 632.0 | Domain | EXS |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 1_177 | 40.333333333333336 | 697.0 | Domain | SPX |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 439_643 | 40.333333333333336 | 697.0 | Domain | EXS |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 158_165 | 40.333333333333336 | 632.0 | Region | Important for inositol polyphosphate binding |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 158_165 | 40.333333333333336 | 697.0 | Region | Important for inositol polyphosphate binding |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 1_236 | 40.333333333333336 | 632.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 258_264 | 40.333333333333336 | 632.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 286_318 | 40.333333333333336 | 632.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 340_345 | 40.333333333333336 | 632.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 369_376 | 40.333333333333336 | 632.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 398_402 | 40.333333333333336 | 632.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 424_473 | 40.333333333333336 | 632.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 497_507 | 40.333333333333336 | 632.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 529_696 | 40.333333333333336 | 632.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 1_236 | 40.333333333333336 | 697.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 258_264 | 40.333333333333336 | 697.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 286_318 | 40.333333333333336 | 697.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 340_345 | 40.333333333333336 | 697.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 369_376 | 40.333333333333336 | 697.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 398_402 | 40.333333333333336 | 697.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 424_473 | 40.333333333333336 | 697.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 497_507 | 40.333333333333336 | 697.0 | Topological domain | Extracellular |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 529_696 | 40.333333333333336 | 697.0 | Topological domain | Cytoplasmic |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 237_257 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 265_285 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 319_339 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 346_368 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 377_397 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 403_423 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 474_496 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367589 | + | 2 | 14 | 508_528 | 40.333333333333336 | 632.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 237_257 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 265_285 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 319_339 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 346_368 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 377_397 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 403_423 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 474_496 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Hgene | XPR1 | chr1:180651547 | chr1:32495899 | ENST00000367590 | + | 2 | 15 | 508_528 | 40.333333333333336 | 697.0 | Transmembrane | Helical |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 34_41 | 127.33333333333333 | 444.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 44_55 | 127.33333333333333 | 444.0 | Compositional bias | DMA/Gly-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 59_89 | 127.33333333333333 | 444.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 34_41 | 127.33333333333333 | 405.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 44_55 | 127.33333333333333 | 405.0 | Compositional bias | DMA/Gly-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 59_89 | 127.33333333333333 | 405.0 | Compositional bias | Pro-rich | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 100_260 | 127.33333333333333 | 444.0 | Region | Involved in homodimerization | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 100_260 | 127.33333333333333 | 405.0 | Region | Involved in homodimerization |
Top |
Fusion Gene Sequence for XPR1-KHDRBS1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000367590_ENST00000327300_TCGA-BR-8060-01A_XPR1_chr1_180651547_+_KHDRBS1_chr1_32495899_length(transcript)=2527nt_BP=319nt GCGGGGAGGGGCGGGGCTATGGAGAGGAGGAGGAAGATGGCGGGCGGGCTGCTCTGAAGAGACCTCGGCGGCGGCGGAGGAGGAGAGAAG CGCAGCGCCGCGCCGCGCCGGGGCCCATGTGGGGAGGAGTCGGAGTCGCTGTTGCCGCCGCCGCCTGTAGCTGCTGGACCCGAGTGGGAG TGAGGGGGAAACGGCAGGATGAAGTTCGCCGAGCACCTCTCCGCGCACATCACTCCCGAGTGGAGGAAGCAATACATCCAGTATGAGGCT TTCAAGGATATGCTGTATTCAGCTCAGGACCAGGCACCTTCTGTGGAAGAAATTGAGAAGATTCAGAAAGGAGACTCAAAAAAGGATGAT GAGGAGAATTACTTGGATTTATTTTCTCATAAGAACATGAAACTGAAAGAGCGAGTGCTGATACCTGTCAAGCAGTATCCCAAGTTCAAT TTTGTGGGGAAGATTCTTGGACCACAAGGGAATACAATCAAAAGACTGCAGGAAGAGACTGGTGCAAAGATCTCTGTATTGGGAAAGGGC TCAATGAGAGACAAAGCCAAGGAGGAAGAGCTGCGCAAAGGTGGAGACCCCAAATATGCCCACTTGAATATGGATCTGCATGTCTTCATT GAAGTCTTTGGACCCCCATGTGAGGCTTATGCTCTTATGGCCCATGCCATGGAGGAAGTCAAGAAATTTCTAGTACCGGATATGATGGAT GATATCTGTCAGGAGCAATTTCTAGAGCTGTCCTACTTGAATGGAGTACCTGAACCCTCTCGTGGACGTGGGGTGCCAGTGAGAGGCCGG GGAGCTGCACCTCCTCCACCACCTGTTCCCAGGGGCCGTGGTGTTGGACCACCTCGGGGGGCTTTGGTACGTGGTACACCAGTAAGGGGA GCCATCACCAGAGGTGCCACTGTGACTCGAGGCGTGCCACCCCCACCTACTGTGAGGGGTGCTCCAGCACCAAGAGCACGGACAGCGGGC ATCCAGAGGATACCTTTGCCTCCACCTCCTGCACCAGAAACATATGAAGAATATGGATATGATGATACATACGCAGAACAAAGTTACGAA GGCTACGAAGGCTATTACAGCCAGAGTCAAGGGGACTCAGAATATTATGACTATGGACATGGGGAGGTTCAAGATTCTTATGAAGCTTAT GGCCAGGACGACTGGAATGGGACCAGGCCGTCGCTGAAGGCCCCTCCTGCTAGGCCAGTGAAGGGAGCATACAGAGAGCACCCATATGGA CGTTATTAAAAACAAACATGAGGGGAAAATATCAGTTATGAGCAAAGTTGTTACTGATTTCTTGTATCTCCCAGGATTCCTGTTGCTTTA CCCACAACAGACAAGTAATTGTCTAAGTGTTTTTCTTCGTGGTCCCCTTCTTCTCCCCACCTTATTCCATTCTTAACTCTGCATTCTGGC TTCTGTATGTAGTATTTTAAAATGAGTTAAAATAGATTTAGGAATATTGAATTAATTTTTTAAGTGTGTAGATGCTTTTTTCTTTGTTGT TTAAATATAAACAGAAGTGTACCTTTTATAATAAAAAAAAGAAGTTGAGTAAAAAAAAAAAACACACAAACCTGTTAGTTTCAAAAATGA CATTGCTTGCTTAAAGGTTCTGAAGTAAAGGCTTGTTAAGTTTCTCTTAGTTTTGATTTGAGGCATCCCGTAAAGTTGTAGTTGCAGAAT CCCAAACTAGGCTACATTTCAAAATTCAGGGCTGTTTAAGATTTAAAATCACAAACATTAACGGCAGTAGGCACCACCATGTAAAAGTGA GCTCAGACGTCTCTAAAAAATGTTTCCTTTATAAAAGCACATGGCGGTTGAATCTTAAGGTTAAATTTTAATATGAAAGATCCTCATGAA TTAAATAGTTGATGCAATTTTTAACGTTAATTGATATAAAAAAAAAAACAACAAAATTAGGCTTGTAAAACTGACTTTTTCATTACGTGG GTTTTGAAATCTAGCCCCAGACATACTGTGTTGAGAGATACTTAGAGGGAGGGAGTAGGTTTTGAAGAGGTTGATGGTGGTGGGGAGGGA AGGCCTCCTGAATTGAGTTTGATGCAGAGCTTTTTAGCCATGAAGAATCTTTCAGTCATAGTACTAATAATTAAATTTTCAGTATTTAAA AAGACAAAGTATTTTGTCCATTTGAGATTCTGCACTCCATGAAAAGTTCACTTGGACGCTGGGGCCAAAAGCTGTTGATTTTCTTAAGTT GACGGTTGTCAATATATCGAACTGTTCCCAAGTTAGTCAAGTATGTCTCAACACTAGCATGATATAAAAAGGGACACTGCAGCTGAATGA AAAAGGAATCAAAATCCACTTTGTACATAAGTTAAAGTCCTAATTGGATTTGTACCGTCCTCCCATTTTGTTCTCGGAAGATTAAATGCT ACATGTGTAAGTCTGCCTAAATAGGTAGCTTAAACTTATGTCAAAATGTCTGCAGCAGTTTGTCAATAAAGTTTAGTCCTTTTTTAATCA >In-frame_ENST00000367590_ENST00000327300_TCGA-BR-8060-01A_XPR1_chr1_180651547_+_KHDRBS1_chr1_32495899_length(amino acids)=356AA_start in transcript=198_stop in transcript=1268 MKFAEHLSAHITPEWRKQYIQYEAFKDMLYSAQDQAPSVEEIEKIQKGDSKKDDEENYLDLFSHKNMKLKERVLIPVKQYPKFNFVGKIL GPQGNTIKRLQEETGAKISVLGKGSMRDKAKEEELRKGGDPKYAHLNMDLHVFIEVFGPPCEAYALMAHAMEEVKKFLVPDMMDDICQEQ FLELSYLNGVPEPSRGRGVPVRGRGAAPPPPPVPRGRGVGPPRGALVRGTPVRGAITRGATVTRGVPPPPTVRGAPAPRARTAGIQRIPL -------------------------------------------------------------- >In-frame_ENST00000367589_ENST00000327300_TCGA-BR-8060-01A_XPR1_chr1_180651547_+_KHDRBS1_chr1_32495899_length(transcript)=2499nt_BP=291nt GGAGGAAGATGGCGGGCGGGCTGCTCTGAAGAGACCTCGGCGGCGGCGGAGGAGGAGAGAAGCGCAGCGCCGCGCCGCGCCGGGGCCCAT GTGGGGAGGAGTCGGAGTCGCTGTTGCCGCCGCCGCCTGTAGCTGCTGGACCCGAGTGGGAGTGAGGGGGAAACGGCAGGATGAAGTTCG CCGAGCACCTCTCCGCGCACATCACTCCCGAGTGGAGGAAGCAATACATCCAGTATGAGGCTTTCAAGGATATGCTGTATTCAGCTCAGG ACCAGGCACCTTCTGTGGAAGAAATTGAGAAGATTCAGAAAGGAGACTCAAAAAAGGATGATGAGGAGAATTACTTGGATTTATTTTCTC ATAAGAACATGAAACTGAAAGAGCGAGTGCTGATACCTGTCAAGCAGTATCCCAAGTTCAATTTTGTGGGGAAGATTCTTGGACCACAAG GGAATACAATCAAAAGACTGCAGGAAGAGACTGGTGCAAAGATCTCTGTATTGGGAAAGGGCTCAATGAGAGACAAAGCCAAGGAGGAAG AGCTGCGCAAAGGTGGAGACCCCAAATATGCCCACTTGAATATGGATCTGCATGTCTTCATTGAAGTCTTTGGACCCCCATGTGAGGCTT ATGCTCTTATGGCCCATGCCATGGAGGAAGTCAAGAAATTTCTAGTACCGGATATGATGGATGATATCTGTCAGGAGCAATTTCTAGAGC TGTCCTACTTGAATGGAGTACCTGAACCCTCTCGTGGACGTGGGGTGCCAGTGAGAGGCCGGGGAGCTGCACCTCCTCCACCACCTGTTC CCAGGGGCCGTGGTGTTGGACCACCTCGGGGGGCTTTGGTACGTGGTACACCAGTAAGGGGAGCCATCACCAGAGGTGCCACTGTGACTC GAGGCGTGCCACCCCCACCTACTGTGAGGGGTGCTCCAGCACCAAGAGCACGGACAGCGGGCATCCAGAGGATACCTTTGCCTCCACCTC CTGCACCAGAAACATATGAAGAATATGGATATGATGATACATACGCAGAACAAAGTTACGAAGGCTACGAAGGCTATTACAGCCAGAGTC AAGGGGACTCAGAATATTATGACTATGGACATGGGGAGGTTCAAGATTCTTATGAAGCTTATGGCCAGGACGACTGGAATGGGACCAGGC CGTCGCTGAAGGCCCCTCCTGCTAGGCCAGTGAAGGGAGCATACAGAGAGCACCCATATGGACGTTATTAAAAACAAACATGAGGGGAAA ATATCAGTTATGAGCAAAGTTGTTACTGATTTCTTGTATCTCCCAGGATTCCTGTTGCTTTACCCACAACAGACAAGTAATTGTCTAAGT GTTTTTCTTCGTGGTCCCCTTCTTCTCCCCACCTTATTCCATTCTTAACTCTGCATTCTGGCTTCTGTATGTAGTATTTTAAAATGAGTT AAAATAGATTTAGGAATATTGAATTAATTTTTTAAGTGTGTAGATGCTTTTTTCTTTGTTGTTTAAATATAAACAGAAGTGTACCTTTTA TAATAAAAAAAAGAAGTTGAGTAAAAAAAAAAAACACACAAACCTGTTAGTTTCAAAAATGACATTGCTTGCTTAAAGGTTCTGAAGTAA AGGCTTGTTAAGTTTCTCTTAGTTTTGATTTGAGGCATCCCGTAAAGTTGTAGTTGCAGAATCCCAAACTAGGCTACATTTCAAAATTCA GGGCTGTTTAAGATTTAAAATCACAAACATTAACGGCAGTAGGCACCACCATGTAAAAGTGAGCTCAGACGTCTCTAAAAAATGTTTCCT TTATAAAAGCACATGGCGGTTGAATCTTAAGGTTAAATTTTAATATGAAAGATCCTCATGAATTAAATAGTTGATGCAATTTTTAACGTT AATTGATATAAAAAAAAAAACAACAAAATTAGGCTTGTAAAACTGACTTTTTCATTACGTGGGTTTTGAAATCTAGCCCCAGACATACTG TGTTGAGAGATACTTAGAGGGAGGGAGTAGGTTTTGAAGAGGTTGATGGTGGTGGGGAGGGAAGGCCTCCTGAATTGAGTTTGATGCAGA GCTTTTTAGCCATGAAGAATCTTTCAGTCATAGTACTAATAATTAAATTTTCAGTATTTAAAAAGACAAAGTATTTTGTCCATTTGAGAT TCTGCACTCCATGAAAAGTTCACTTGGACGCTGGGGCCAAAAGCTGTTGATTTTCTTAAGTTGACGGTTGTCAATATATCGAACTGTTCC CAAGTTAGTCAAGTATGTCTCAACACTAGCATGATATAAAAAGGGACACTGCAGCTGAATGAAAAAGGAATCAAAATCCACTTTGTACAT AAGTTAAAGTCCTAATTGGATTTGTACCGTCCTCCCATTTTGTTCTCGGAAGATTAAATGCTACATGTGTAAGTCTGCCTAAATAGGTAG >In-frame_ENST00000367589_ENST00000327300_TCGA-BR-8060-01A_XPR1_chr1_180651547_+_KHDRBS1_chr1_32495899_length(amino acids)=356AA_start in transcript=170_stop in transcript=1240 MKFAEHLSAHITPEWRKQYIQYEAFKDMLYSAQDQAPSVEEIEKIQKGDSKKDDEENYLDLFSHKNMKLKERVLIPVKQYPKFNFVGKIL GPQGNTIKRLQEETGAKISVLGKGSMRDKAKEEELRKGGDPKYAHLNMDLHVFIEVFGPPCEAYALMAHAMEEVKKFLVPDMMDDICQEQ FLELSYLNGVPEPSRGRGVPVRGRGAAPPPPPVPRGRGVGPPRGALVRGTPVRGAITRGATVTRGVPPPPTVRGAPAPRARTAGIQRIPL -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for XPR1-KHDRBS1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 351_443 | 127.33333333333333 | 444.0 | HNRNPA1 | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 351_443 | 127.33333333333333 | 405.0 | HNRNPA1 | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000327300 | 0 | 9 | 400_420 | 127.33333333333333 | 444.0 | ZBTB7A | |
Tgene | KHDRBS1 | chr1:180651547 | chr1:32495899 | ENST00000492989 | 0 | 8 | 400_420 | 127.33333333333333 | 405.0 | ZBTB7A |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for XPR1-KHDRBS1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for XPR1-KHDRBS1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | XPR1 | C4225335 | BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6 | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | XPR1 | C0004782 | Basal Ganglia Diseases | 1 | CTD_human |
Hgene | XPR1 | C0006663 | Calcinosis | 1 | CTD_human |
Hgene | XPR1 | C0015371 | Extrapyramidal Disorders | 1 | CTD_human |
Hgene | XPR1 | C0015624 | Fanconi Syndrome | 1 | GENOMICS_ENGLAND |
Hgene | XPR1 | C0263628 | Tumoral calcinosis | 1 | CTD_human |
Hgene | XPR1 | C0393590 | Fahr's syndrome (disorder) | 1 | ORPHANET |
Hgene | XPR1 | C0521174 | Microcalcification | 1 | CTD_human |
Hgene | XPR1 | C0750951 | Lenticulostriate Disorders | 1 | CTD_human |